← Open Payments lookup

KATHLEEN MACKENZIE: Open Payments

NPI 1942715818 · DAYVILLE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$966 in 46 payments from 9 companies in 2025. Trend: 2023 $1,528 · 2024 $723 · 2025 $966

Food & beverage: $954Education: $12
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$188
Vanda Pharmaceuticals Inc.9$170
Teva Pharmaceuticals USA, Inc.7$162
ABBVIE INC.10$135
E.R. Squibb & Sons, L.L.C.6$103
Otsuka America Pharmaceutical, Inc.4$82
Neurocrine BioSciences, Inc.2$56
Alkermes, Inc.3$55
Xeris Pharmaceuticals, Inc.1$15

Products named: CAPLYTA, FANAPT, VRAYLAR, UZEDY, COBENFY, REXULTI, INGREZZA, ARISTADA.

Industry payments across CT — which companies pay providers there.